The Incannex (ASX:IHL) share price has lost 20% in 4 weeks. What's happening?

Incannex shares recently reversed their upward momentum. Read on for more details.

| More on:
A woman holds her hands to her face in shock and fear with a worried expression on her face as many ASX 200 shares hit 52-week lows today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Incannex Healthcare Ltd (ASX: IHL) share price has taken a beating over the past four weeks, having come off its all-time high of 44.5 cents on 2 September.

Prior to this, Incannex shares rallied from mid-August until this point. So, what's happened to reverse the climb for this medicinal cannabis company?

Read on for more details.

What's up with the Incannex share price lately?

The Incannex share price soared in August after the company advised it had filed an F-1 Registration form with the US Securities and Exchange Commission (SEC).

An F-1 registration is like an initial public offering (IPO) on the ASX, except it is reserved for companies domiciled outside of the US.

The key difference is that F-1 applicants complete a US public offering of American Depositary Shares (ADS) instead.

Each ADS represents 50 Incannex shares and trades on the American exchanges just like any ordinary share would.

Incannex shares jumped from 27.5 cents on the day of the announcement to an all-time high a few weeks later. 

But Incannex shares cooled off as September began, coinciding with the time it released its FY21 earnings results.  

In its report, the company recognised a 214% year over year increase in revenue, but this didn't carry through to its net profit after tax (NPAT).

In fact, the company recorded an almost 74% loss from ordinary activities that mushroomed to $8.2 million. As such, the company's net loss for the year ballooned 82% deeper into the red from FY20.

Investors weren't impressed by the healthcare company's results at all. In the days following the release, the Incannex share price started its march south.

So, it appears that investor sentiment has shifted for Incannex as selling pressures mount on its share price.

Share price snapshot

At the time of writing, Incannex is trading at 35 cents, down 2.82% today. That's also a 21% loss over 4 weeks.

On a longer-term view, the Incannex share price has been a major outperformer over the past year to date, climbing 130% into the green.

That builds to a 331% return over the past 12 months for Incannex shareholders. This is well ahead of the 25% gains recorded by the S&P/ASX 200 Index (ASX: XJO) over the past year.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

three excited doctors with hands in the air
Healthcare Shares

Why Macquarie forecasts a 22% upside for this ASX All Ords healthcare stock

Macquarie expects a big rebound ahead for this ASX healthcare stock. But why?

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Healthcare Shares

Guess which ASX All Ords stock is jumping 9% on $1.6b market opportunity

This small cap is having a big day. But why?

Read more »

A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
Healthcare Shares

75% upside: Broker tips two ASX healthcare shares

This broker sees big potential in these two Australian healthcare companies 

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

What does the Macquarie Hospital Claims Index mean for ASX 200 health insurance stocks?

Macquarie shares its view on Medibank Private and NIB Holdings.

Read more »

Two lab workers fist pump each other.
Broker Notes

What's JP Morgan's price target on CSL shares?

Are CSL shares undervalued or will they continue to underperform?

Read more »

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

2 ASX healthcare stocks making huge moves on big news

These shares are getting investors excited today. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Healthcare Shares

Which ASX All Ords stock is up 15% on guidance upgrade?

Let's find out what is getting investors excited on Tuesday.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

3 reasons why the Sigma Healthcare share price could be a buy

This business has a very exciting outlook.

Read more »